C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/14 (2006.01) A61K 31/5377 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2698818
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).
La présente invention concerne un composé représenté par la formule (I) ou un sel pharmaceutiquement acceptable de celui-ci : qui est utilisé pour le traitement préventif et/ou thérapeutique d'une maladie causée par une activité anormale de la protéine TAU kinase 1, telle que des maladies neurodégénératives (notamment la maladie d'Alzheimer).
Sakai Daiki
Watanabe Kazutoshi
Fetherstonhaugh & Co.
Sanofi-Aventis
LandOfFree
3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl)... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1906652